KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 3.369
AS - Asia 1.613
EU - Europa 1.190
SA - Sud America 373
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 102
OC - Oceania 2
Totale 6.829
Nazione #
US - Stati Uniti d'America 3.285
SG - Singapore 478
RU - Federazione Russa 332
IT - Italia 305
VN - Vietnam 301
BR - Brasile 298
CN - Cina 268
HK - Hong Kong 243
BD - Bangladesh 124
FR - Francia 112
IE - Irlanda 109
SE - Svezia 88
GB - Regno Unito 67
IN - India 56
CA - Canada 42
DE - Germania 42
CI - Costa d'Avorio 36
AR - Argentina 25
FI - Finlandia 24
MX - Messico 24
PL - Polonia 23
AT - Austria 20
NL - Olanda 20
ZA - Sudafrica 20
IQ - Iraq 16
TR - Turchia 15
ES - Italia 13
ID - Indonesia 13
JP - Giappone 13
EC - Ecuador 12
MA - Marocco 12
VE - Venezuela 12
PY - Paraguay 10
PH - Filippine 9
PK - Pakistan 9
CO - Colombia 8
SA - Arabia Saudita 7
TH - Thailandia 7
DZ - Algeria 6
JM - Giamaica 6
KE - Kenya 6
UA - Ucraina 6
UZ - Uzbekistan 6
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
Totale 6.648
Città #
Ashburn 667
Des Moines 380
San Jose 317
Singapore 312
Chandler 310
Hong Kong 237
Council Bluffs 159
Dallas 119
Dublin 108
Boardman 99
Ho Chi Minh City 88
Beijing 75
Hanoi 71
Fairfield 68
The Dalles 67
Los Angeles 61
Lauterbourg 60
New York 54
Moscow 44
Hefei 39
Milan 38
Abidjan 36
Ancona 35
Buffalo 32
Lawrence 30
Princeton 30
San Mateo 28
Wilmington 28
Pune 25
Houston 24
Orem 24
Santa Clara 23
São Paulo 23
Turin 22
Woodbridge 22
Helsinki 21
Rome 21
Seattle 21
Warsaw 20
Nuremberg 19
Falls Church 18
Phoenix 18
Montreal 17
Cambridge 16
Marche 16
Chicago 15
Rio de Janeiro 15
Da Nang 14
Ann Arbor 13
Columbus 12
Frankfurt am Main 12
Tokyo 12
Vienna 12
Haiphong 11
San Diego 11
Stockholm 11
Washington 11
Denver 10
San Francisco 10
Boston 9
Manchester 9
Naples 9
Shanghai 9
Amsterdam 8
Atlanta 8
Brasília 8
Chennai 8
London 8
Toronto 8
Ankara 7
Brooklyn 7
Johannesburg 7
Mexico City 7
Norwalk 7
Bangkok 6
Bologna 6
Dong Ket 6
Falconara Marittima 6
Guayaquil 6
Istanbul 6
Medellín 6
Miami 6
Miano 6
Tashkent 6
Amman 5
Baghdad 5
Campinas 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Portsmouth 5
Southwark 5
Asunción 4
Belo Horizonte 4
Bến Tre 4
Cape Town 4
Dhaka 4
Elk Grove Village 4
Guarulhos 4
Hangzhou 4
Totale 4.362
Nome #
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 209
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 168
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 161
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 142
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 138
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 138
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 133
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 131
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 128
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues. Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 127
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 126
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 124
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 123
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 123
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 119
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 117
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 116
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 115
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 114
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 114
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 112
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 111
Cluster stability in the analysis of mass cytometry data 111
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 106
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 105
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 104
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 104
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 103
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 101
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 101
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 99
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 99
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 97
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy 96
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 96
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 93
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 92
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 91
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 90
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 89
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 89
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 87
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 84
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 82
Natural born survivors: The inglorious TP53 82
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 76
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 75
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 75
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 75
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 71
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 69
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 69
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 68
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 68
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 66
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 65
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 64
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 64
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 63
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 63
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 62
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 62
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 59
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 58
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 58
Functional characterization of CD4+ T cells in aplastic anemia 57
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 57
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 55
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 54
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 53
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 52
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 46
High frequency of CD95+/CD45RA− regulatory T cells defines an immunosuppressive profile associated with MDS progression 17
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia 11
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM‐prognostic score (FCM‐PS) for overall survival 7
Totale 6.829
Categoria #
all - tutte 33.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022329 0 79 0 1 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/20251.241 75 117 46 18 47 73 202 64 254 74 111 160
2025/20263.402 170 169 174 207 322 236 654 328 345 351 236 210
2026/2027282 184 98 0 0 0 0 0 0 0 0 0 0
Totale 6.829